drugset / Trial / NCT01569516
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
Phase 2
Unknown
288 enrolled
Changchun Huayang High-tech Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to evaluate the safety and efficacy of Octohydroaminoacridine Succinate tablets and find the optimal dose in patients with mild to moderate Alzheimer's Disease.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-07
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OCTAAMINOACRIDINE | Small molecule | 1 mg | — |
| Subject | OCTAAMINOACRIDINE | Small molecule | 2 mg | — |
| Subject | OCTAAMINOACRIDINE | Small molecule | 4 mg | — |